BIBLIOTECA · STUDII EVALUATE INTER PARES

Știința
nutriției,
la sursă

Studii despre substanțele pe care le urmărim, colectate zilnic din baza europeană Europe PMC. Fiecare își păstrează titlul, autorii, revista și un link către articolul original, fie că este sau nu favorabilă pentru ceea ce vindem.

01Doar reviste evaluate inter pares, indexate în PubMed
02Colectare automată, fără selecție după rezultatele unui studiu
03Întotdeauna un link către articolul original
04Nivelul de dovezi indicat pentru fiecare studiu

Studiile

Studii: 277 din 2421
Ștergeți căutarea și filtrele
Nivel 2 · Studiu controlatStudiu randomizat controlat2023

Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial

Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A · Clinical nutrition (Edinburgh, Scotland)

Background & aims : Recent randomized clinical trials have raised concerns regarding potential off target adverse effects from supplementation of n-3 polyunsaturated fatty acids (PUFA) on atrial fibrillation (AF) risk. We aimed to assess risk and potential mediators of AF and 'micro-AF' from n-3 PUFA in…

Nivel 2 · Studiu controlatStudiu randomizat controlat2023

A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles

Tikkanen JT, Soliman EZ, Pester J, Danik JS, Gomelskya N, Copeland T, Lee IM, Buring JE, Manson JE, Cook NR, Albert CM · Scientific reports

Beneficial and adverse associations with arrhythmias have been reported for omega-3 fatty acids (omega-3 FA) and Vitamin D. The 12 lead electrocardiogram (ECG) contains quantitative measures reflecting diverse aspects of electrophysiology that might provide insights into mechanisms underlying these associations. In a…

Nivel 2 · Studiu controlatStudiu randomizat controlat2023

Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Indicated and Selective Prevention of Depression in Older Adults: Results From the Clinical Center Sub-Cohort of the VITamin D and OmegA-3 TriaL (VITAL)

Vyas CM, Mischoulon D, Chang G, Cook NR, Weinberg A, Copeland T, Kang JH, Bubes V, Friedenberg G, LeBoff MS, Lee IM, Buring JE, Manson JE, Reynolds CF, Okereke OI · The Journal of clinical psychiatry

Nivel 1 · SintezăMetaanaliză2023

Does omega-3 supplementation improve the inflammatory profile of patients with heart failure? a systematic review and meta-analysis

Prokopidis K, Therdyothin A, Giannos P, Morwani-Mangnani J, Ferentinos P, Mitropoulos A, Isanejad M · Heart failure reviews

Omega-3 fatty acids are potential anti-inflammatory agents that may exert beneficial outcomes in diseases characterised by increased inflammatory profile. The purpose of this study was to comprehensively evaluate the existing research on the effectiveness of n-3 fatty acid supplementation in lowering levels of…

Nivel 2 · Studiu controlatStudiu randomizat controlat2023

The Effect of a Fish Oil and/or Probiotic Intervention from Early Pregnancy Onwards on Colostrum Immune Mediators: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial in Overweight/Obese Mothers

Soukka J, Polari L, Kalliomäki M, Saros L, Laajala TD, Vahlberg T, Toivola DM, Laitinen K · Molecular nutrition & food research

Scope : Modifying the composition of colostrum by external factors may provide opportunities to improve the infant's health. Here, we evaluated how fish oil and/or probiotics supplementation modify concentrations of colostrum immune mediators and their associations with perinatal clinical factors on mothers with…

Nivel 3 · Studiu pe oameniStudiu observațional2023

Development and internal validation of a non-invasive clinical tool to predict sufficient omega-3 levels in early pregnancy

Fu JY, Wang CA, Liu G, Mead E, Phung J, Makrides M, Pennell CE · BMC pregnancy and childbirth

Background : Complications from preterm birth (PTB) are the leading cause of death and disability in those under five years. Whilst the role of omega-3 (n-3) supplementation in reducing PTB is well-established, growing evidence suggests supplementation use in those replete may increase the risk of early PTB. Aim : To…

Nivel 1 · SintezăMetaanaliză2023

Effect of omega-3 polyunsaturated fatty acids supplementation for patients with osteoarthritis: a meta-analysis

Deng W, Yi Z, Yin E, Lu R, You H, Yuan X · Journal of orthopaedic surgery and research

Background : Omega-3 polyunsaturated fatty acids (n-3 PUFAs) confers anti-inflammatory efficacy, which has been suggested to be effective for patients with osteoarthritis (OA). However, previous studies evaluating the influence of n-3 PUFAs supplementation in patients with OA showed inconsistent results. We performed…

Nivel 2 · Studiu controlatStudiu randomizat controlat2023

Lipid profile after omega-3 supplementation in neonates with intrauterine growth retardation: a randomized controlled trial

Elsheikh M, El Amrousy D, El-Mahdy H, Dawoud H, Harkan A, El-Barky A · Pediatric research

Background : Neonates with intrauterine growth restriction (IUGR) have a high lipid profile that predisposes them to cardiovascular disease later in life. We aimed to evaluate the effect of omega 3 supplementation on serum leptin level, lipid profile, and growth in neonates with IUGR. Methods : This clinical trial was…

Nivel 1 · SintezăEvaluare sistematică2023

Need for Multidimensional and Multidisciplinary Management of Depressed Preadolescents and Adolescents: A Review of Randomized Controlled Trials on Oral Supplementations (Omega-3, Fish Oil, Vitamin D3)

Pruneti C, Guidotti S · Nutrients

(1) Background: Depression is a serious health problem with a high cost for public administration. Epidemiological studies report that one in five children have a mental disorder and about 50% of mental health problems exacerbate in childhood and adolescence. Moreover, the antidepressant efficacy in children and…

Nivel 2 · Studiu controlatStudiu randomizat controlat2023

Clinical and microbiological outcomes of subgingival instrumentation supplemented with high-dose omega-3 polyunsaturated fatty acids in periodontal treatment - a randomized clinical trial

Stańdo-Retecka M, Piatek P, Namiecinska M, Bonikowski R, Lewkowicz P, Lewkowicz N · BMC oral health

Purpose : This study aimed to evaluate the impact of dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) combined with scaling and root planing (SRP) in untreated periodontitis stage III and IV. Methods : Forty patients were randomly…

Nivel 2 · Studiu controlatStudiu randomizat controlat2023

Potential Modulation of Inflammation and Physical Function by Combined Probiotics, Omega-3 Supplementation and Vitamin D Supplementation in Overweight/Obese Patients with Chronic Low-Grade Inflammation: A Randomized, Placebo-Controlled Trial

Kopp L, Schweinlin A, Tingö L, Hutchinson AN, Feit V, Jähnichen T, Lehnert K, Vetter W, Rings A, Jensen MG, Brummer RJ, Bischoff SC · International journal of molecular sciences

Obesity is characterized by low-grade inflammation and increased gut permeability. Here, we aim to evaluate the effect of a nutritional supplement on these parameters in subjects with overweight and obesity. A double-blinded, randomized clinical trial was conducted in 76 adults with overweight or obesity (BMI 28 to…

Nivel 1 · SintezăMetaanaliză2023

Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials

Huang L, Zhang F, Xu P, Zhou Y, Liu Y, Zhang H, Tan X, Ge X, Xu Y, Guo M, Long Y · Advances in nutrition (Bethesda, Md.)

The current guidelines recommend that people consume 2 or more servings of fat-rich fish per week to obtain enough omega-3 (ω-3) polyunsaturated fatty acids to prevent cardiovascular events. However, the cardiovascular benefits of ω-3 polyunsaturated fatty acids in patients with diabetes are unclear, and related…

Cum citim un studiu
în 5 întrebări

  1. 01Unde a fost publicat?Într-o revistă evaluată inter pares, identificabilă (PubMed, DOI).
  2. 02Cine a fost studiat?Oameni? Câți? De ce vârstă, în ce stare de sănătate?
  3. 03Cum?Randomizat, controlat cu placebo, dublu-orb?
  4. 04Ce doză?Este aceeași cu cea din produsul care vi se vinde?
  5. 05Cine a finanțat?Finanțările și conflictele de interese sunt declarate la sfârșitul articolului.

Glosar

Evaluare inter pares
Înainte de publicare, articolul este evaluat de cercetători independenți din același domeniu.
Studiu randomizat
Participanții sunt repartizați aleatoriu în grupuri, astfel încât grupurile să fie comparabile.
Dublu-orb
Nici participanții, nici cercetătorii nu știu cine primește ce pe durata studiului.
Metaanaliză
O analiză statistică ce combină rezultatele mai multor studii pe aceeași întrebare.
Evaluare sistematică
O trecere în revistă a tuturor studiilor publicate pe o temă, după o metodă anunțată dinainte.
Studiu observațional
Cercetătorii observă persoane fără a le atribui o intervenție: arată o asociere, nu o cauză.

Informații științifice; nu înlocuiesc sfatul unui profesionist din domeniul sănătății. Prezența unui studiu în această bibliotecă nu constituie o mențiune privind produsele noastre.

Selecție automată: articole indexate în PubMed al căror titlu menționează o substanță pe care o urmărim, clasificate drept metaanaliză, evaluare sistematică, studiu clinic sau studiu observațional. Sursa referințelor: Europe PMC.